{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:44:51Z","timestamp":1792035891806,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272915"],"award-info":[{"award-number":["82272915"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U24A20816"],"award-info":[{"award-number":["U24A20816"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573677"],"award-info":[{"award-number":["82573677"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["CXTD2022007"],"award-info":[{"award-number":["CXTD2022007"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023MD734246"],"award-info":[{"award-number":["2023MD734246"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025T180577"],"award-info":[{"award-number":["2025T180577"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tips.2026.02.004","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:33:49Z","timestamp":1773898429000},"page":"386-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cuproptosis in cancer: emerging mechanism and therapeutic opportunities"],"prefix":"10.1016","volume":"47","author":[{"given":"Wenyan","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta E.","family":"Burden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lorraine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7964-1342","authenticated-orcid":false,"given":"Huizhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.02.004_bb0005","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tips.2026.02.004_bb0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","article-title":"Cuproptosis: a copper-triggered modality of mitochondrial cell death","volume":"32","author":"Tang","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.tips.2026.02.004_bb0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.tips.2023.07.004","article-title":"Copper homeostasis and cuproptosis in cardiovascular disease therapeutics","volume":"44","author":"Yang","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2026.02.004_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118893","article-title":"Copper metabolism as a unique vulnerability in cancer","volume":"1868","author":"Shanbhag","year":"2021","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.tips.2026.02.004_bb0025","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300474R","article-title":"Adrenomedullin\/FOXO3 enhances sunitinib resistance in clear cell renal cell carcinoma by inhibiting FDX1 expression and cuproptosis","volume":"37","author":"Wang","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2026.02.004_bb0030","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.02.004_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105046","article-title":"FDX1 regulates cellular protein lipoylation through direct binding to LIAS","volume":"299","author":"Dreishpoon","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.02.004_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107995","article-title":"Engineered bacterial lipoate protein ligase A (lplA) restores lipoylation in cell models of lipoylation deficiency","volume":"300","author":"Bick","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.02.004_bb0045","article-title":"Pan-cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators","volume":"2","author":"Wu","year":"2022","journal-title":"Imeta"},{"key":"10.1016\/j.tips.2026.02.004_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.189013","article-title":"Cuproptosis and cuproptosis-related genes: emerging potential therapeutic targets in breast cancer","volume":"1878","author":"Liu","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.tips.2026.02.004_bb0055","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s11426-024-2316-4","article-title":"Modifying metabolic and immune hallmarks of cancer by a copper complex","volume":"68","author":"Chu","year":"2025","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.tips.2026.02.004_bb0060","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","article-title":"Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance","volume":"43","author":"Lei","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.02.004_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt1241","article-title":"Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair","volume":"11","author":"Chiang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2026.02.004_bb0070","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/hmg\/ddt585","article-title":"Mutations in the lipoyltransferase LIPT1 gene cause a fatal disease associated with a specific lipoylation defect of the 2-ketoacid dehydrogenase complexes","volume":"23","author":"Tort","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2026.02.004_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/inorganics10040052","article-title":"The intriguing role of iron-sulfur clusters in the CIAPIN1 protein family","volume":"10","author":"Ciofi-Baffoni","year":"2022","journal-title":"Inorganics"},{"key":"10.1016\/j.tips.2026.02.004_bb0080","article-title":"Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma","volume":"4","author":"Xing","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.tips.2026.02.004_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41401-023-01167-7","article-title":"Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma","volume":"45","author":"Yang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.tips.2026.02.004_bb0090","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.cmet.2024.07.009","article-title":"Zinc transporter 1 functions in copper uptake and cuproptosis","volume":"36","author":"Li","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2026.02.004_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1477971","article-title":"Novel insights into cuproptosis inducers and inhibitors","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tips.2026.02.004_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102891","article-title":"Novel insights into anticancer mechanisms of elesclomol: more than a prooxidant drug","volume":"67","author":"Gao","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.tips.2026.02.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202204733","article-title":"An enzyme-engineered nonporous copper(I) coordination polymer nanoplatform for cuproptosis-based synergistic cancer therapy","volume":"34","author":"Xu","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tips.2026.02.004_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303694","article-title":"Mild-photothermal effect induced high efficiency ferroptosis-boosted-cuproptosis based on Cu2O@Mn3Cu3O8 nanozyme","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tips.2026.02.004_bb0115","doi-asserted-by":"crossref","first-page":"0335","DOI":"10.34133\/research.0335","article-title":"Hyperbaric oxygen boosts antitumor efficacy of copper-diethyldithiocarbamate nanoparticles against pancreatic ductal adenocarcinoma by regulating cancer stem cell metabolism","volume":"7","author":"Xiao","year":"2024","journal-title":"Research"},{"key":"10.1016\/j.tips.2026.02.004_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101911","article-title":"Metal-organic framework nanoagent induces cuproptosis for effective immunotherapy of malignant glioblastoma","volume":"51","author":"Huang","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.tips.2026.02.004_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101144","article-title":"Un-methylation of NUDT21 represses docosahexaenoic acid biosynthesis contributing to enzalutamide resistance in prostate cancer","volume":"77","author":"Lin","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.tips.2026.02.004_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s10020-025-01127-3","article-title":"CYFIP1 coordinate with RNMT to induce osteosarcoma cuproptosis via AURKAIP1 m7G modification","volume":"31","author":"Lin","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.tips.2026.02.004_bb0135","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","article-title":"Hypoxia inducible factor-1\u03b1 drives cancer resistance to cuproptosis","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.02.004_bb0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-023-01732-y","article-title":"Cuproptosis: mechanisms and links with cancers","volume":"22","author":"Xie","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tips.2026.02.004_bb0145","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.molcel.2024.11.013","article-title":"p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis","volume":"85","author":"Liao","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2026.02.004_bb0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41419-023-06264-3","article-title":"MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2026.02.004_bb0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2025.10.028","article-title":"Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia","volume":"189","author":"Lewis","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.02.004_bb0160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.ccell.2025.04.013","article-title":"Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis","volume":"43","author":"Dang","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.02.004_bb0165","article-title":"AKT1 phosphorylates FDX1 to promote cuproptosis resistance in triple-negative breast cancer","volume":"12","author":"Sun","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.02.004_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110173","article-title":"Essential metals in health and disease","volume":"367","author":"Jomova","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tips.2026.02.004_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142797","article-title":"STEAP proteins: roles in disease biology and potential for therapeutic intervention","volume":"309","author":"Cai","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tips.2026.02.004_bb0180","doi-asserted-by":"crossref","first-page":"7066","DOI":"10.3390\/molecules27207066","article-title":"Recent advances in copper-based organic complexes and nanoparticles for tumor theranostics","volume":"27","author":"Tsymbal","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.tips.2026.02.004_bb0185","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","article-title":"Copper metabolism in cell death and autophagy","volume":"19","author":"Xue","year":"2023","journal-title":"Autophagy"},{"key":"10.1016\/j.tips.2026.02.004_bb0190","article-title":"A metabolic perspective on cuproptosis","author":"Li","year":"2025","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tips.2026.02.004_bb0195","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","article-title":"Targeting cuproplasia and cuproptosis in cancer","volume":"21","author":"Tang","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tips.2026.02.004_bb0200","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2026.02.004_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","article-title":"The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer","volume":"10","author":"Guo","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2026.02.004_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.23-47","article-title":"Iron from the gut: the role of divalent metal transporter 1","volume":"74","author":"Okazaki","year":"2024","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.tips.2026.02.004_bb0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10238-024-01302-6","article-title":"Role of zinc in health and disease","volume":"24","author":"Stiles","year":"2024","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.tips.2026.02.004_bb0220","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/s41418-024-01341-2","article-title":"Dysregulated Wnt\/\u03b2-catenin signaling confers resistance to cuproptosis in cancer cells","volume":"31","author":"Liu","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tips.2026.02.004_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114301","article-title":"4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer","volume":"159","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tips.2026.02.004_bb0230","doi-asserted-by":"crossref","first-page":"29579","DOI":"10.1038\/s41598-024-81317-x","article-title":"NFE2L2 and SLC25A39 drive cuproptosis resistance through GSH metabolism","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tips.2026.02.004_bb0235","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2018.10.001","article-title":"A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: an NRG oncology\/gynecologic oncology group study","volume":"151","author":"Monk","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tips.2026.02.004_bb0240","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12885-021-08242-4","article-title":"A phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker","volume":"21","author":"Kelley","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tips.2026.02.004_bb0245","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4149","article-title":"Effect of disulfiram and copper plus chemotherapy vs chemotherapy alone on survival in patients with recurrent glioblastoma: a randomized clinical trial","volume":"6","author":"Werlenius","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.tips.2026.02.004_bb0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1631\/jzus.B2200405","article-title":"Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway","volume":"24","author":"Yuan","year":"2023","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"10.1016\/j.tips.2026.02.004_bb0255","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13148-025-01900-5","article-title":"A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches","volume":"17","author":"Liu","year":"2025","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.tips.2026.02.004_bb0260","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/ph14121241","article-title":"In vitro and clinical compassionate use experiences with the drug-repurposing approach cUSP9v3 in glioblastoma","volume":"14","author":"Halatsch","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.tips.2026.02.004_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202308241","article-title":"Self-destructive copper carriers induce pyroptosis and cuproptosis for efficient tumor immunotherapy against dormant and recurrent tumors","volume":"36","author":"Qiao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tips.2026.02.004_bb0270","doi-asserted-by":"crossref","first-page":"13805","DOI":"10.1021\/jacs.3c14247","article-title":"Enzyme core spherical nucleic acid that enables enhanced cuproptosis and antitumor immune response through alleviating tumor hypoxia","volume":"146","author":"Huang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tips.2026.02.004_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103260","article-title":"Tumor microenvironment activation amplify oxidative stress promoting tumor energy remodeling for mild photothermal therapy and cuproptosis","volume":"75","author":"Qiao","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.tips.2026.02.004_bb0280","article-title":"An ellagic acid coordinated copper-based nanoplatform for efficiently overcoming cancer chemoresistance by cuproptosis and synergistic inhibition of cancer cell stemness","volume":"20","author":"Lu","year":"2024","journal-title":"Small (Weinheim an der Bergstrasse, Germany)"},{"key":"10.1016\/j.tips.2026.02.004_bb0285","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1039\/D2TB01150F","article-title":"Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis","volume":"10","author":"Lu","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.tips.2026.02.004_bb0290","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.841814","article-title":"Selective targeting of cancer cells by copper ionophores: an overview","volume":"9","author":"Oliveri","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.tips.2026.02.004_bb0295","doi-asserted-by":"crossref","first-page":"19581","DOI":"10.1021\/acsnano.3c07775","article-title":"Cuproptosis: harnessing transition metal for cancer therapy","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.02.004_bb0300","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13046-022-02485-0","article-title":"Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy","volume":"41","author":"Zheng","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.tips.2026.02.004_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.celbio.2025.100126","article-title":"Covalent organic framework eliciting a click-based intracellular copper accumulation cascade for cuproptosis cancer therapy","volume":"1","author":"Liu","year":"2025","journal-title":"Cell Biomater."},{"key":"10.1016\/j.tips.2026.02.004_bb0310","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12935-024-03253-0","article-title":"Extracellular vesicles produced by irradiated endothelial or glioblastoma stem cells promote tumor growth and vascularization modulating tumor microenvironment","volume":"24","author":"Castellani","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.tips.2026.02.004_bb0315","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.3390\/cancers16234054","article-title":"The in vitro cytotoxic effect of elesclomol on breast adenocarcinoma cells is enhanced by concurrent treatment with glycolytic inhibitors","volume":"16","author":"Modica-Napolitano","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.tips.2026.02.004_bb0320","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1186\/s12967-023-04533-5","article-title":"Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications","volume":"21","author":"Tarin","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tips.2026.02.004_bb0325","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00109-023-02414-4","article-title":"FDA-approved disulfiram as a novel treatment for aggressive leukemia","volume":"102","author":"Karsa","year":"2024","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.tips.2026.02.004_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2023.140921","article-title":"Comparison of force fields to study the zinc-finger containing protein NPL4, a target for disulfiram in cancer therapy","volume":"1871","author":"Scrima","year":"2023","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.tips.2026.02.004_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121335","article-title":"Leveraging disulfiram to treat cancer: mechanisms of action, delivery strategies, and treatment regimens","volume":"281","author":"Lu","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.tips.2026.02.004_bb0340","article-title":"A systematic review of literatures: to identify non-cancer drugs repurposed for lung cancer","author":"Samadder","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/j.tips.2026.02.004_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108218","article-title":"Targeting cuproptosis by zinc pyrithione in triple-negative breast cancer","volume":"26","author":"Yang","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.tips.2026.02.004_bb0350","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/antiox13020173","article-title":"Male reproductive toxicity of antifouling chemicals: insights into oxidative stress-induced infertility and molecular mechanisms of zinc pyrithione (ZPT)","volume":"13","author":"Panga","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.tips.2026.02.004_bb0355","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s11658-024-00608-3","article-title":"Cuproptosis in cancer: biological implications and therapeutic opportunities","volume":"29","author":"Li","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.tips.2026.02.004_bb0360","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.3390\/polym16172418","article-title":"Injectable hydrogel-encapsulating pickering emulsion for overcoming lenvatinib-resistant hepatocellular carcinoma via cuproptosis induction and stemness inhibition","volume":"16","author":"Li","year":"2024","journal-title":"Polymers"},{"key":"10.1016\/j.tips.2026.02.004_bb0365","article-title":"(2024) CD44 and its implication in neoplastic diseases","volume":"5","author":"Xu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.tips.2026.02.004_bb0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/or.2025.8942","article-title":"Widespread activation and critical role of EMT and stemness in the neuroendocrine differentiation of prostate cancer (review)","volume":"54","author":"Li","year":"2025","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tips.2026.02.004_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1646890","article-title":"Mechanism and application of copper-based nanomedicines in activating tumor immunity through oxidative stress modulation","volume":"16","author":"Xia","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2026.02.004_bb0380","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1021\/jacsau.4c00712","article-title":"Signaling mechanism of cuproptosis activating cGAS-STING immune pathway","volume":"4","author":"Zhu","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.tips.2026.02.004_bb0385","doi-asserted-by":"crossref","first-page":"40129","DOI":"10.1021\/acsami.5c07234","article-title":"A self-amplifying MOF nanoplatform for cancer immunotherapy synergizing starvation-enhanced cuproptosis and cGAS-STING activation","volume":"17","author":"Zhang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.tips.2026.02.004_bb0390","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1016\/j.apsb.2024.04.028","article-title":"Inhalable nanoparticles with enhanced cuproptosis and cGAS-STING activation for synergistic lung metastasis immunotherapy","volume":"14","author":"Yan","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tips.2026.02.004_bb0395","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.tips.2024.10.016","article-title":"Advances in cell therapy: progress and challenges in hematological and solid tumors","volume":"45","author":"D\u2019Avanzo","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2026.02.004_bb0400","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12951-025-03186-4","article-title":"Zinc-copper bimetallic nanoplatforms trigger photothermal-amplified cuproptosis and cGAS-STING activation for enhancing triple-negative breast cancer immunotherapy","volume":"23","author":"Zhou","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.tips.2026.02.004_bb0405","article-title":"Mitochondria-Targeted multifunctional nanoparticles combine cuproptosis and programmed cell death-1 downregulation for cancer immunotherapy Adv","volume":"11","author":"Li","year":"2024","journal-title":"Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.02.004_bb0410","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","article-title":"Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity","volume":"44","author":"Wu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2026.02.004_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-025-01641-1","article-title":"MTF1 attenuates ferroptosis and cuproptosis synergistic potentiation in gastric cancer","author":"Luan","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tips.2026.02.004_bb0420","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.cmet.2023.08.008","article-title":"Death-seq identifies regulators of cell death and senolytic therapies","volume":"35","author":"Colville","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.tips.2026.02.004_bb0425","article-title":"Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.tips.2026.02.004_bb0430","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s12672-025-02696-9","article-title":"Unraveling the significance of cuproptosis in hepatocellular carcinoma heterogeneity and tumor microenvironment through integrated single-cell sequencing and machine learning approaches","volume":"16","author":"Liu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.tips.2026.02.004_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202370152","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tips.2026.02.004_bb0440","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.4103\/NRR.NRR-D-24-00642","article-title":"Copper homeostasis and neurodegenerative diseases","volume":"20","author":"Wang","year":"2025","journal-title":"Neural Regen. Res."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:32:02Z","timestamp":1776123122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0165614726000374"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.02.004","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cuproptosis in cancer: emerging mechanism and therapeutic opportunities","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}